Otros
Meformin and LY294002 treatment regulate angiogenesis process through PI3K-MAPK/AKT/mTOR signaling pathways in mammary tumors.
Fecha
2018-01-01Registro en:
Clinical Cancer Research. Philadelphia: Amer Assoc Cancer Research, v. 24, n. 1, p. 77-78, 2018.
1078-0432
WOS:000419180000127
Autor
Universidade de São Paulo (USP)
Universidade Estadual Paulista (Unesp)